Carmen Perrino to Retrospective Studies
This is a "connection" page, showing publications Carmen Perrino has written about Retrospective Studies.
Connection Strength
0.262
-
Perrino CM, Eble J, Kao CS, Whaley RD, Cheng L, Idrees M, Hashemi-Sadraei N, Monn MF, Kaimakliotis HZ, Bandali E, Grignon D. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients. Hum Pathol. 2019 08; 90:27-36.
Score: 0.066
-
Perrino CM, Ho A, Dall CP, Zynger DL. Utility of GATA3 in the differential diagnosis of pheochromocytoma. Histopathology. 2017 Sep; 71(3):475-479.
Score: 0.058
-
Perrino CM, Wang JF, Collins BT. Microphthalmia transcription factor immunohistochemistry for FNA biopsy of ocular malignant melanoma. Cancer Cytopathol. 2015 Jul; 123(7):394-400.
Score: 0.049
-
Perrino CM, Fichtenbaum EJ, Pohar KS, Zynger DL. Challenges in the pathological reporting of urothelial carcinoma involving prostatic transurethral resection specimens within a single institution. Pathology. 2013 12; 45(7):664-9.
Score: 0.045
-
Magers MJ, Perrino CM, Cramer HM, Wu HH. Cytomorphologic comparison of type 1 and type 2 papillary renal cell carcinoma: A retrospective analysis of 28 cases. Cancer Cytopathol. 2019 06; 127(6):370-376.
Score: 0.016
-
Matoso A, Idrees MT, Rodriguez FJ, Ibrahim J, Perrino CM, Ulbright TM, Epstein JI. Neuroglial Differentiation and Neoplasms in Testicular Germ Cell Tumors Lack Immunohistochemical Evidence of Alterations Characteristic of Their CNS Counterparts: A Study of 13 Cases. Am J Surg Pathol. 2019 03; 43(3):422-431.
Score: 0.016
-
Joehlin-Price AS, Perrino CM, Stephens J, Backes FJ, Goodfellow PJ, Cohn DE, Suarez AA. Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables. Gynecol Oncol. 2014 Apr; 133(1):43-7.
Score: 0.011